| Death‐associated protein kinase (DAPK) family modulators: current and future therapeutic outcomes AK Farag, EJ Roh Medicinal Research Reviews 39 (1), 349-385, 2019 | 109 | 2019 |
| Targeting EGFR/HER2 tyrosine kinases with a new potent series of 6-substituted 4-anilinoquinazoline hybrids: Design, synthesis, kinase assay, cell-based assay, and molecular … A Elkamhawy, AK Farag, ANI Viswanath, TM Bedair, DG Leem, KT Lee, ... Bioorganic & Medicinal Chemistry Letters 25 (22), 5147-5154, 2015 | 40 | 2015 |
| Reprofiling of pyrimidine-based DAPK1/CSF1R dual inhibitors: identification of 2, 5-diamino-4-pyrimidinol derivatives as novel potential anticancer lead compounds AK Farag, AHE Hassan, BS Ahn, KD Park, EJ Roh Journal of enzyme inhibition and medicinal chemistry 35 (1), 311-324, 2020 | 35 | 2020 |
| Novel LCK/FMS inhibitors based on phenoxypyrimidine scaffold as potential treatment for inflammatory disorders AK Farag, A Elkamhawy, AM Londhe, KT Lee, AN Pae, EJ Roh European Journal of Medicinal Chemistry 141, 657-675, 2017 | 32 | 2017 |
| First-in-class DAPK1/CSF1R dual inhibitors: Discovery of 3, 5-dimethoxy-N-(4-(4-methoxyphenoxy)-2-((6-morpholinopyridin-3-yl) amino) pyrimidin-5-yl) benzamide as a potential … AK Farag, AHE Hassan, H Jeong, Y Kwon, JG Choi, MS Oh, KD Park, ... European Journal of Medicinal Chemistry 162, 161-175, 2019 | 29 | 2019 |
| Diarylurea derivatives comprising 2, 4-diarylpyrimidines: Discovery of novel potential anticancer agents via combined failed-ligands repurposing and molecular hybridization … AK Farag, AHE Hassan, KS Chung, JH Lee, HS Gil, KT Lee, EJ Roh Bioorganic Chemistry 103, 104121, 2020 | 23 | 2020 |
| Identification of novel potential VEGFR-2 inhibitors using a combination of computational methods for drug discovery MM Al-Sanea, G Chilingaryan, N Abelyan, A Sargsyan, S Hovhannisyan, ... Life 11 (10), 1070, 2021 | 15 | 2021 |
| Adenosine-induced vasospasticity in a myocardial bridge… endothelial dysfunction? A Farag, Y Al-Najjar, J Eichhöfer JACC: Cardiovascular Interventions 8 (2), e21-e22, 2015 | 11 | 2015 |
| AKF-D52, a synthetic Phenoxypyrimidine-urea derivative, triggers extrinsic/intrinsic apoptosis and cytoprotective autophagy in human non-small cell lung cancer cells HS Gil, JH Lee, AK Farag, AHE Hassan, KS Chung, JH Choi, EJ Roh, ... Cancers 13 (22), 5849, 2021 | 6 | 2021 |
| Design, synthesis, and biological evaluation of pseudo-bicyclic pyrimidine-based compounds as potential EGFR inhibitors AK Farag, BS Ahn, JS Yoo, R Karam, EJ Roh Bioorganic Chemistry 126, 105918, 2022 | 4 | 2022 |
| Design, synthesis, and biological evaluation of novel pyrido-dipyrimidines as dual topoisomerase II/FLT3 inhibitors in leukemia cells MA Abdelgawad, FEA Mohamed, PF Lamie, SNA Bukhari, MM Al-Sanea, ... Bioorganic Chemistry 122, 105752, 2022 | 3 | 2022 |
| Pacemaker clinics and anticoagulation for atrial fibrillation. VS Vassiliou, A Farag, E McIntosh, I Williams Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology …, 2012 | 3 | 2012 |
| Intra-operative use of impedance planimetry during surgery for fecal incontinence A Farag, J O’Dea Gastroenterology 148 (4), S827-S827, 2015 | 2 | 2015 |
| AF8c, a Multi-Kinase Inhibitor Induces Apoptosis by Activating DR5/Nrf2 via ROS in Colorectal Cancer Cells S Jeong, AK Farag, HK Yun, YA Jeong, DY Kim, MJ Jo, SH Park, BR Kim, ... Cancers 14 (13), 3043, 2022 | 1 | 2022 |
| 82 Out of sight but not out of mind. A district hospital cardiology teleclinic setup… patients’, sustainability and environmental benefits A Farag, P Mullineux, W Matthews, M Carimichael, C Barlow Heart 107 (Suppl 1), A66-A67, 2021 | 1 | 2021 |
| Thioredoxin Protection Against Hyperglycemia-Induced Mitochondrial Hyperfission in Human Endocardial Endothelial Cells A Ibrahim, A Farag, M Ansari Cardiovascular Revascularization Medicine 65, 71, 2024 | | 2024 |
| 500.34 Thioredoxin Protection Against Hyperglycemia-Induced Mitochondrial Hyperfission in Human Endocardial Endothelial Cells A Ibrahim, A Farag, M Ansari Cardiovascular Interventions 17 (4_Supplement), S58-S58, 2024 | | 2024 |
| Porphyrin-Based Brain Tumor-Targeting Agents: [64Cu]Cu-porphyrin and [64Cu]Cu-TDAP C Im, JH Ahn, AK Farag, S Kim, JY Kim, YJ Lee, JA Park, CM Kang Molecular Pharmaceutics 20 (11), 5856-5864, 2023 | | 2023 |
| 152 Ct-derived fractional flow reserve–outcomes from a district general hospital-led service Y Kasolo, A Farag Heart 108 (Suppl 1), A117-A118, 2022 | | 2022 |
| P07 David vs. Goliath: CTCA versus invasive angiography in previous bypass patients presenting with NSTEACS S Hill, S Thiru, A Farag Heart 106 (Suppl 3), A7-A7, 2020 | | 2020 |
Ahmed H.E. HassanDepartment of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University在 mans.edu.eg 的电子邮件经过验证
Ahmed H.E. HassanDepartment of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University在 mans.edu.eg 的电子邮件经过验证
Mohammad M. Al-SaneaJouf University在 ju.edu.sa 的电子邮件经过验证